(R)-Tegoprazan
Product Specifications
UNSPSC Description
(R)-Tegoprazan ((R)-CJ-12420; example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research[1].
Target Antigen
Proton Pump
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/r-tegoprazan.html
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CN(C)C(C1=CC(O[C@H]2C3=C(F)C=C(F)C=C3OCC2)=C4C(N=C(N4)C)=C1)=O
Molecular Weight
387.38
References & Citations
[1]Takeshi Hanazawa, et al. Chromane Substituted Benzimidazole Derivatives. US20070142448A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-17623C/R-Tegoprazan-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-17623C/R-Tegoprazan-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
942195-56-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6458194-01 0.1 mL
PLA2G4E (Cytosolic Phospholipase A2 epsilon, cPLA2-epsilon, Phospholipase A2 group IVE, PLA2G4E) (MaxLight 650)
Ask
View Details 
MBS6458194-02 5x 0.1 mL
PLA2G4E (Cytosolic Phospholipase A2 epsilon, cPLA2-epsilon, Phospholipase A2 group IVE, PLA2G4E) (MaxLight 650)
Ask
View Details 